首页|期刊导航|中华医学杂志(英文版)|Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
Mingyang Shao Menglin Chen Jiayin Yang Yujun Shi Tianfu Wen Hong Bu Qing Tao Yahong Xu Qing Xu Yuke Shu Yuwei Chen Junyi Shen Yongjie Zhou Zhenru Wu
中华医学杂志(英文版)2023,Vol.136Issue(17):2066-2076,11.
中华医学杂志(英文版)2023,Vol.136Issue(17):2066-2076,11.DOI:10.1097/CM9.0000000000002380
Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
摘要
关键词
Hepatocellular carcinoma/Glutamine synthetase/Molecular stratification/Targeted therapyKey words
Hepatocellular carcinoma/Glutamine synthetase/Molecular stratification/Targeted therapy引用本文复制引用
Mingyang Shao,Menglin Chen,Jiayin Yang,Yujun Shi,Tianfu Wen,Hong Bu,Qing Tao,Yahong Xu,Qing Xu,Yuke Shu,Yuwei Chen,Junyi Shen,Yongjie Zhou,Zhenru Wu..Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy[J].中华医学杂志(英文版),2023,136(17):2066-2076,11.基金项目
The project was supported by grants from the Natural Science Foundation of China(No.82072689),the 1.3.5 Project for Disciplines of Excellence,West China Hospital,Sichuan University(No.2020HXFH010),the China Postdoctoral Science Foundation Grant(No.2021M692304),and the PostDoctor Research Project,West China Hospital,Sichuan University(Nos.2020HXBH069,2021HXBH031). (No.82072689)